The nasal polyps market is growing due to an upsurge in allergies and infections, which cause chronic nasal inflammation. This is further exacerbated by increased occurrences of genetic mutations linked to the immune system, leading to abnormal mucus production in the nasal and sinus linings.

1. Nasal Polyps
Market Research
Report 2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Nasal Polyps Market 2023-2033
According to IMARC Group’s latest report, titled “Nasal Polyps Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and
Forecast 2023-2033”, the 7 major nasal polyps markets reached a value of US$ 65.7 Million in 2022. Looking forward, IMARC Group expects the
7MM to reach US$ 106.3 Million by 2033, exhibiting a growth rate (CAGR) of 4.48% during 2023-2033. This report can serve as an excellent
guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Industry Definition and Application:
Nasal polyps refer to a medical condition with soft, painless growths on the lining of the nasal passage or sinuses. They are noncancerous and
often occur in the area where the sinuses open into the nasal cavity. Nasal polyps can be single or multiple and vary in size from small to large.
The common symptoms of this ailment include a runny nose, persistent stuffiness, postnasal drip, decreased or absent sense of smell, facial
pain, frequent nosebleeds, headache, snoring, pain in the upper teeth, a sense of pressure over the forehead and face, etc. The diagnosis of
the illness is typically based on the patient’s medical history, clinical features, and a general physical test. Nasal endoscopy is further
recommended for patients who want a detailed examination of the nose and sinuses. The healthcare professional may also perform imaging
studies, like a computerized tomography (CT) scan, to evaluate the location and size of polyps in deeper areas of the sinuses and rule out other
possible blockages in the nasal cavity. 3

4. Report Description and Highlights
What are the growth prospects and trends in the industry?
The nasal polyps market is growing due to an upsurge in allergies and infections, which cause chronic nasal inflammation. This is further
exacerbated by increased occurrences of genetic mutations linked to the immune system, leading to abnormal mucus production in the
nasal and sinus linings. Intranasal corticosteroid injections such as fluticasone favored over traditional oral drugs due to their superior
effectiveness and minimized systemic side effects, are also fueling market expansion.
Moreover, the growing preference for image-guided endoscopic sinus surgery, which bolsters accuracy, lessens complications and
optimizes surgical results, is positively influencing the market. The escalating demand for biological drugs, which specifically target proteins
or cells to alleviate nasal swelling and irritation, is projected to propel the nasal polyps market in the future.
Request a Sample Report: https://www.imarcgroup.com/nasal-polyps-market/requestsample
4

5. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
5

6. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Nasal Polyps market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Nasal Polyps market
• Reimbursement scenario in the market
• In-market and pipeline drugs
6

7. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/nasal-polyps-market
7

8. Key Questions Answered in the Report
1. How has the Nasal Polyps Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Nasal Polyps Market across the seven major markets in 2022 and what will it look like in 2033?
4. What is the growth rate of the Nasal Polyps Market across the seven major markets and what will be the expected growth over the
next ten years?
5. What are the key unmet needs in the market?
8

9. Table of
Contents

10. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
10

11. Table of Contents
4 Nasal Polyps - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Nasal Polyps - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/nasal-polyps-market/toc
11

12. Partial List Of Our Clients
12

13. OUR CLIENTS
13

14. Disclaimer
14
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.